| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 551-11-1 | dinoprost | glandin cyclosin dinoprost PGF2ALPHA enzaprost dinolytic cyclosin enzaprostf enzaprost dinolytic amoglandin enzaprostf Prostaglandin F2A PROSTAGLANDIN F2ALPHA prostaglandin F2-alpha 9,11,15-trihydroxyprosta-5,13-dien-1-oic acid 9,11,15-trihydroxyprosta-5,13-dien-1-oicacid 9ALPHA,11ALPHA,15S-TRIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID (9alpha,11alpha,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid | ||
| 2 | 180469-63-0 | 5-iPF2α-VI | 5-iPF2α-VI (5-iPF2.alpha.-VI 5-iPF2α-VI Exclusive 5-iso prostaglandin F2α-VI Prosta-6,14-dien-1-oic acid, 5,9,11-trihydroxy-, (5S,6E,8β,9α,11α,14Z)- | ||
| 3 | 23518-25-4 | (+-)-PGF2-alpha | PIGF-2 (+-)-PGF2α (+-)-PGF2-alpha dl-Prostaglandin F2α Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S)-(+-)- 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-, (+-)- (8CI) | ||
| 4 | 745-65-3 | Prostaglandin E1 | PGE1 ent-PGE1 ALPROSTADIL Prostaglandin E1 Alprostadil (PGE1) l-cyclopentaneheptanoicaci Alprostadil (prostandin E1) Prostaglandin E1 or AIPROSTADIL Alprostadil (PGE1)／Prostaglandin E1 11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (11alpha,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oate Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15S)- (8S,11S,12S,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid l-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoicacid (11alpha,12xi,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid | ||
| 5 | PGF2ALPHA [1-14C] | PROSTAGLANDIN F2ALPHA [1-14C] PGF2ALPHA [1-14C] | |||
| 6 | 1445349-99-4 | 8,12-iso-iPF2α-VI | 8,12-iso-iPF2α-VI 8,12-iso-iPF2.alpha.-VI | ||
| 7 | 38360-96-2 | (+)-Prostaglandin E1 | (+)-Prostaglandin E1 Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (8β,11β,12α,13E,15R)- | ||
| 8 | 20348-58-7 | (+-)-Prostaglandin E1 | (+-)-Prostaglandin E1 Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)-(+-)- Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)-(±)- (9CI) | ||
| 9 | 20897-91-0 | 15(R)-PROSTAGLANDIN E1 | 15(R)-PGE1 15-EPI PGE1 15(R)-PROSTAGLANDIN E1 15(R)-Prostaglandin E1 GMVPRGQOIOIIMI-CHCORRSHSA-N 9-oxo-11α,15R-dihydroxy-prost-13E-en-1-oic acid 9-OXO-11ALPHA,15R-DIHYDROXY-PROST-13E-EN-1-OIC ACID (13E,15R)-11α,15-Dihydroxy-9-oxoprost-13-en-1-oic acid | ||
| 10 | 24570-01-2 | 11BETA-PROSTAGLANDIN E1 | 11BETA-PROSTAGLANDIN E1 | ||
| 11 | 38776-77-1 | 10-Deoxygrayanotoxin III | 10-Deoxygrayanotoxin III Grayanotoxane-3,5,6,14,16-pentol, (3β,6β,10α,14R)- (9CI) | ||
| 12 | 177020-26-7 | 8-ISO PROSTAGLANDIN F2BETA | 8-ISO-9BETA-PGF2ALPHA 8-iso Prostaglandin F2β 8-ISO PROSTAGLANDIN F2BETA PXGPLTODNUVGFL-HMALSPAFSA-N 8-isoprostaglandin PGF2beta 9BETA,11ALPHA,15S-TRIHYDROXY-(8BETA)-PROSTA-5Z,13E-DIEN-1-OIC ACID 9alpha,11alpha,15S-trihydroxy-(8beta)-prost-5Z,13E-dien-1-oic-acid (Z)-7-[(1S,2R,3R,5R)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid | ||
| 13 | 37658-84-7 | 15(R)-PROSTAGLANDIN F2ALPHA | 15-beta PGF2α 15-EPI PGF2ALPHA 15(R)-Prostaglandin F2α 15(R)-PROSTAGLANDIN F2ALPHA PXGPLTODNUVGFL-CKXCCYAOSA-N Dinoprost trometamol EP Impurity B 9ALPHA, 11ALPHA, 15R-TRIHYDROXY-PROSTA-5Z, 13E-DIEN-1-OIC ACID Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15R)- | ||
| 14 | 159812-83-6 | ent-8-iso Prostaglandin F2α | ent-8-iso Prostaglandin F2α PXGPLTODNUVGFL-VCKDCIDJSA-N ent-8-iso Prostaglandin F2.alpha. | ||
| 15 | 21562-58-3 | 15-KETO PROSTAGLANDIN F1ALPHA | 15-keto Prostaglandin F1α 15-KETO PROSTAGLANDIN F1ALPHA 15-keto Prostaglandin F1α MaxSpec? Standard 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-PROST-13E-EN-1-OIC ACID Prost-13-en-1-oic acid, 9,11-dihydroxy-15-oxo-, (9α,11α,13E)- | ||
| 16 | 38432-87-0 | 11BETA-PROSTAGL AND IN F2ALPHA | 11BETA-PROSTAGL AND IN F2ALPHA | ||
| 17 | 4510-16-1 | 9BETA, 11ALPHA-PROSTAGLANDIN F2 | 9BETA, 11ALPHA-PROSTAGLANDIN F2 | ||
| 18 | 214748-65-9 | 8-ISO-15(R)-PROSTAGLANDIN F2ALPHA | PXGPLTODNUVGFL-PGWUFSIFSA-N 8-iso-15(R)-Prostaglandin F2α 8-ISO-15(R)-PROSTAGLANDIN F2ALPHA 8-ISO-15-EPI PROSTAGLANDIN F2ALPHA 9ALPHA,11ALPHA,15R-TRIHYDROXY-(8BETA)-PROSTA-5Z,13E-DIEN-1-OIC ACID Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,8β,9α,11α,13E,15R)- | ||
| 19 | 214748-66-0 | ent-8-iso-15(S)-Prostaglandin F2α | PXGPLTODNUVGFL-XNTKLVSTSA-N ent-8-iso-15(S)-Prostaglandin F2α ent-8-iso-15(R)-Prostaglandin F2.alpha. Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9β,11β,12α,13E,15S)- | ||
| 20 | 5094-14-4 | 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1 | U 21002 13,14-dihydro-15-keto PGE1 CDUVSQMTLOYKTR-ZHALLVOQSA-N 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E1 9,15-dioxo-11α-hydroxy-prostan-1-oic acid 9,15-DIOXO-11ALPHA-HYDROXY-PROSTAN-1-OIC ACID Prostan-1-oic acid, 11-hydroxy-9,15-dioxo-, (11α)- 15-Keto Prostaglandin E0DISCONTINUED, OFFER K202056 | ||
| 21 | 95560-45-5 | Dihexyl-4,5-epoxyhexahydro-1,2-phthalate | Dihexyl-4,5-epoxyhexahydro-1,2-phthalate 4,5-epoxy-cyclohexane-1,2-dicarboxylic acid dihexyl ester | ||
| 22 | 27376-76-7 | 13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA | 13,14-dihydro-15-keto PGF2a 13,14-dihydro-15-ketoprostaglandin F2A 15-keto-13,14-dihydroprostaglandinf2alpha 13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA (5Z)-9α,11α-Dihydroxy-15-oxoprost-5-en-1-oic acid 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-PROST-5Z-EN-1-OIC ACID (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid | ||
| 23 | 102910-23-6 | 5,12,20-trihydroxy-6,8,14-eicosatrienoic acid | 5,12,20-trihydroxy-6,8,14-eicosatrienoic acid 6,8,14-Eicosatrienoic acid, 5,12,20-trihydroxy-, [S-[R*,R*-(Z,E,Z)]]- (9CI) | ||
| 24 | 102910-24-7 | 5,12,20-trihydroxy-8,10,14-eicosatrienoic acid | 5,12,20-trihydroxy-8,10,14-eicosatrienoic acid 8,10,14-Eicosatrienoic acid, 5,12,20-trihydroxy-, [S-[R*,S*-(E,E,Z)]]- (9CI) | ||
| 25 | 8-ISO-13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA | 8-ISO-13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA 9ALPHA,11ALPHA-DIHYDROXY-15-OXO-(8BETA)-PROST-5Z-EN-1-OIC ACID | |||
| 26 | 17968-82-0 | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID | ||
| 27 | 96790-36-2 | (5E,9E,14E)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid | Trioxilin a (5E,9E,14E)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid | ||
| 28 | (5Z,8Z,12E)-11,14,15-trihydroxyicosa-5,8,12-trienoic acid | (5Z,8Z,12E)-11,14,15-trihydroxyicosa-5,8,12-trienoic acid 11,14,15-THETA | |||
| 29 | 67008-19-9 | (13E,15S)-6,9α-Epoxy-11α,15-dihydroxyprost-13-en-1-oic acid | PGI1 Prostaglandin I1 (13E,15S)-6,9α-Epoxy-11α,15-dihydroxyprost-13-en-1-oic acid | ||
| 30 | 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid dihexyl ester | 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid dihexyl ester | |||
| 31 | 68860-46-8 | (5Z,9E,11R,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid | 8,11,12-Teta Trioxilin A3 8,11,12-Trihydroxy-5,9,14-icosatrienoic acid 8,11,12-trihydroxy-5,9,14-eicosatrienoic acid 5,9,14-Eicosatrienoic acid, 8,11,12-trihydroxy- (5Z,9E,11R,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid | ||
| 32 | (5Z,8Z,11S,12R,14Z)-10,11,12-trihydroxyicosa-5,8,14-trienoic acid | (5Z,8Z,11S,12R,14Z)-10,11,12-trihydroxyicosa-5,8,14-trienoic acid Troxilin B3 | |||
| 33 | 152561-64-3 | (+)-1-Decarboxy-1-methyl-20-nor-19-carboxyprostaglandin F(sub 2-alpha) | (+)-1-Decarboxy-1-methyl-20-nor-19-carboxyprostaglandin F(sub 2-alpha) Prosta-5,13-dien-20-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S)- (9CI) | ||
| 34 | 191919-02-5 | (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid | VKTIONYPMSCHQI-JPRPWBOBSA-N 8-iso-13,14-dihydro-15-keto-PGF2a 8-iso-13,14-dihydro-15-keto Prostaglandin F2α (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid | ||
| 35 | (4Z,9E)-6,8-Dihydroxy-4,8-dimethyl-11-(1-methylethyl)-14-oxopentadeca-4,9-dienoic acid | (4Z,9E)-6,8-Dihydroxy-4,8-dimethyl-11-(1-methylethyl)-14-oxopentadeca-4,9-dienoic acid | |||
| 36 | 119314-69-1 | 7-[(1R,2S,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent yl]heptanoic acid | MR 256 7-[(1R,2S,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent yl]heptanoic acid | ||
| 37 | 67441-54-7 | 4-(5-Hydroxy-4,8-dimethyl-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid | 4-(5-Hydroxy-4,8-dimethyl-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid 3,8-Dioxabicyclo(3.2.1)octane-1-acetic acid, 4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl- 3,8-Dioxabicyclo[3.2.1]octane-1-acetic acid, 4-(5-hydroxy-4,8-dimethyl-7-nonenyl)-4-methyl- (9CI) | ||
| 38 | 99877-56-2 | 2-Hydroxy-9-[3-(5-hydroxy-3-hydroxymethyl-3-pentenyl)-2-methyloxiranyl]-2,6-dimethyl-3-nonen-5-one | Pretomexanthol 2-Hydroxy-9-[3-(5-hydroxy-3-hydroxymethyl-3-pentenyl)-2-methyloxiranyl]-2,6-dimethyl-3-nonen-5-one (E)-2-hydroxy-9-[3-[(Z)-5-hydroxy-3-(hydroxymethyl)pent-3-enyl]-2-methyloxiran-2-yl]-2,6-dimethylnon-3-en-5-one | ||
| 39 | 90639-07-9 | (2S,αS,α'R)-α-(Hydroxymethyl)-α'-[[(1R)-1,2,3,4,4a,7,8,8aα-octahydro-5-(hydroxymethyl)-1,2α,4aβ-trimethylnaphthalen-1α-yl]methyl]-2,2-oxiranedimethanol | PR-1389 (2S,αS,α'R)-α-(Hydroxymethyl)-α'-[[(1R)-1,2,3,4,4a,7,8,8aα-octahydro-5-(hydroxymethyl)-1,2α,4aβ-trimethylnaphthalen-1α-yl]methyl]-2,2-oxiranedimethanol | ||
| 40 | 53823-01-1 | (5'R,3S,2R,4''aR)-4,5,3',4',3'',4'',4a'',5'',6'',7'',8'',8a''-Dodecahydro-5''α-(hydroxymethyl)-2''α,5'',8''aβ-trimethyldispiro[furan-3(2H),2'(5'H)-furan-5',1''(2''H)-naphthalene]-2,6''β-diol | Lasiocoryin (5'R,3S,2R,4''aR)-4,5,3',4',3'',4'',4a'',5'',6'',7'',8'',8a''-Dodecahydro-5''α-(hydroxymethyl)-2''α,5'',8''aβ-trimethyldispiro[furan-3(2H),2'(5'H)-furan-5',1''(2''H)-naphthalene]-2,6''β-diol |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|